Mitomycin chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to gynecological cancer.

Examines the efficacy of mitomycin pleurodesis on the treatment of end stage malignant effusion in the United States. Association of diffuse alveolar injury with bleomycin pleurodesis; Decline of prolonged hospital stay and treatment time; Symptomatic improvement of cervical cancer.